Calcimedica, INC Schedule 13D activist filings

Alafi Capital Company LLC and Christopher D. Alafi have filed an amendment to their Schedule 13D, reporting the receipt of new warrants in CalciMedica, Inc. following stockholder approval.

Bering Partners II, L.P. and related entities have filed an amendment to their Schedule 13D, disclosing a beneficial ownership of 9.99% in CalciMedica, Inc., primarily through warrants and common stock.

Alafi Capital Company LLC and Christopher D. Alafi have reported beneficial ownership of 17.1% of CalciMedica, Inc. common stock following a recent private placement.

Bering Partners II, L.P. and related entities have disclosed their beneficial ownership of CalciMedica, Inc. common stock, representing a 6.9% stake following a recent private placement.

Valence Investments and key individuals report changes in beneficial ownership of CalciMedica, Inc. common stock, including participation in a recent public offering.